Severity
Moderate
FDA Devices recall · Reported February 15, 2017
The Empowr PS Insert was reported as missing the impaction slot feature.
Encore Medical, Lp recalled Empowr PS Knee Tibial Insert; Model 343-14-709 The EMPOWR PS tibial insert are made from… - a moderate-severity action.
Empowr PS Knee Tibial Insert; Model 343-14-709 The EMPOWR PS tibial insert are made from… was recalled by Encore Medical, Lp in February 15, 2017. Reason: The Empowr PS Insert was reported as missing the impaction slot feature.. Check the official notice for the remedy. Verify recall #Z-1139-2017 with the FDA Devices before acting.
The recall
Encore Medical, Lp issued this moderate-severity FDA Devices recall-The Empowr PS Insert was reported as missing the impaction slot feature..
Sourced from official FDA Devices enforcement records. Verify recall #Z-1139-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1139-2017) was formally reported on February 15, 2017, with the manufacturer initiating the action on January 10, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. Encore Medical, Lp is listed as the recalling firm, operating out of Austin, TX. Federal records list the affected scope as 24 units.
The documented reason for this recall is: The Empowr PS Insert was reported as missing the impaction slot feature. Distribution data in the federal record shows the product reached: Nationwide Distribution to CO, NY, and FL. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
24 units
Related Recalls
6
3 from same agency
Empowr PS Knee Tibial Insert; Model 343-14-709 The EMPOWR PS tibial insert are made from Highly Cross-Linked Vitamin E (HXL VE) UHMWPE. The tibial insert implants are intended to mate with tibial base implants.
The Empowr PS Insert was reported as missing the impaction slot feature.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1139-2017 |
| Date reported | February 15, 2017 |
| Date initiated | January 10, 2017 |
| Recalling firm | Encore Medical, Lp |
| Firm location | Austin, TX |
| Affected scope | 24 units |
| Distribution | Nationwide Distribution to CO, NY, and FL |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported February 15, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.